More than $6 million in cancer research grants were awarded to Moffitt Cancer Center researchers Wednesday.
U.S. Rep. Kathy Castor announced six new awards as part of the federal American Recovery and Reinvestment Act, designed to stimulate the economy and create jobs.
All of the projects previously had been submitted to the National Institutes of Health for grant consideration. Moffitt has submitted or is planning to apply for more than 80 NIH programs supported by the stimulus. The newest awards go to:
•Almost $2.9 million to Srikumar Chellappan to examine the role of human genes in the progression of non-small-cell lung cancer
•$783,190 to Javier F. Torres-Roca to validate a genetic model predicting responses to radiation therapy
•$684,700 to Edward Seto to investigate the interaction of enzymes and certain proteins in the progression of cancer
•$498,000 to Claudio Anasetti to evaluate effectiveness of a new compound to control life-threatening complications associated with bone marrow transplants
•$459,000 to David Evans to examine the role specific genes play in attention deficits resulting from nicotine withdrawal
•$404,030 to John Koomen to use mass spectrometry, similar to methods used for drug testing in athletes, to detect and assess a cancer of the plasma cell using blood and urine collected from patients.
The state previously had provided Moffitt with an additional $1.5 million in stimulus money for cancer research. Moffitt officials predict the potential for several hundred new jobs as part of the grants.
In recent months, Castor has also announced a $2.7 million award for community health centers in Pinellas, Manatee and Hillsborough counties.
Advertisement
Advertisement